ATRA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $9.48

Kapitalisasi Pasar (MRQ) $90M

P/E (TTM) -5.5

EPS (TTM) $-1.73

Pendapatan (TTM) $6M

ROE (TTM) 46.3%

Rentang 52M $4–$19

ATRA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 1

Tanggal ex-dividen	Pemecahan	Tipe
20 Juni 2024	1-for-25	Terbalik

Tentang Atara Biotherapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Wikidata ↗

sektorHealthcare industriBiotechnology karyawan10 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$121M

2022-12-31 → 2025-12-31

EPS$2.57

2020-12-31 → 2025-12-31

Arus Kas Bebas$-51M

2016-12-31 → 2025-12-31

Margin bersih-269.4%

2023-12-31 → 2025-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	ATRA	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-5.5rata-rata 5T ≈-27.9	≈-27.9	·	·
P/S (TTM)	14.5rata-rata 5T ≈71.2	≈71.2	70.6	Kurang nilai
P/B (MRQ)	-2.4rata-rata 5T ≈34.7	≈34.7	·	·
Price / FCF (Harga / FCF)	-1.4rata-rata 5T ≈-39.1	≈-39.1	·	·
Price / Cash Flow (Harga / Arus Kas)	-1.4rata-rata 5T ≈-40.7	≈-40.7	·	·
Price / Tangible Book (Harga / Nilai Buku Berwujud)	7.2rata-rata 5T ≈68.3	≈68.3	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	ATRA	rata-rata 5T	Median Rekan	Kesimpulan
Margin Operasi (TTM)	-229.7%rata-rata 5T ≈-1084.8%	≈-1084.8%	-2434.3%	Tingkat teratas
EBITDA Margin (Margin EBITDA)	29.7%rata-rata 5T ≈-1084.8%	≈-1084.8%	-2434.3%	Tingkat teratas
Margin Sebelum Pajak (TTM)	-269.0%rata-rata 5T ≈-1086.6%	≈-1086.6%	-3416.0%	Tingkat teratas
Margin Laba Bersih (TTM)	-269.4%rata-rata 5T ≈-1086.7%	≈-1086.7%	-2336.0%	Tingkat teratas
ROA (TTM)	-57.6%rata-rata 5T ≈-46.4%	≈-46.4%	-30.1%	Tingkat teratas
ROE (TTM)	46.3%rata-rata 5T ≈21.8%	≈21.8%	-50.0%	Lemah
ROIC	-93.0%rata-rata 5T ≈-14.5%	≈-14.5%	-52.7%	Lemah

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	ATRA	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)	2.0rata-rata 5T ≈1.9	≈1.9	5.3	Likuiditas rendah
Rasio Cepat (MRQ)	1.5rata-rata 5T ≈1.7	≈1.7	3.8	Likuiditas rendah
Interest Coverage (Cakupan Bunga)	9.5rata-rata 5T ≈-20.3	≈-20.3	·	·

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	Tren 5 Tahun	ATRA	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)		-6.3%rata-rata 5T ≈437.1%	≈437.1%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)		23.8%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	ATRA	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$2.57rata-rata 5T ≈$-15.98	≈$-15.98	·	·
Revenue / Share (Pendapatan / Saham)	$9.50rata-rata 5T ≈$8.93	≈$8.93	·	·
Cash Flow / Share (Arus Kas / Saham)	$-4.01rata-rata 5T ≈$-4.41	≈$-4.41	·	·
Cash / Share (Kas / Saham)	$1.16rata-rata 5T ≈$1.56	≈$1.56	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	ATRA	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	1.9rata-rata 5T ≈0.9	≈0.9	0.0	Tingkat teratas
Receivables Turnover (Perputaran Piutang)	88.3rata-rata 5T ≈31.9	≈31.9	·	·
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$12.1M	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 76.0%

Laporan Berikutnya Nov 10, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Agu 10, 2026	$-0.32	$-0.32	0.40%
31 Maret 2026	Mei 13, 2026	$-0.29	$-0.41	29.8%
31 Des. 2025		$-0.25	$-0.17	-43.0%
30 Sep. 2025		$-0.32	$-0.88	63.5%
30 Juni 2025		$0.19	$-0.47	140.5%
31 Maret 2025		$3.50	$-2.02	273.3%
31 Des. 2024		$-1.19	$-3.65	67.4%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 16

Metrik	2025	2024	2023	2022
Revenue	$121M	$129M	$9M	$64M
R&D Expense	$37M	$151M	$225M	$273M
SG&A Expense	$26M	$40M	$51M	$72M
Operating Expenses	$85M	$212M	$285M	$344M
Operating Income	$36M	$-83M	$-276M	$-281M
Interest Expense	$4M	$5M	$5M	$373.0K
Interest Income	$683.0K	$2M	$5M	$3M
Other Non-op	$-34.0K	$528.0K	$-246.0K	$-700.0K
Pretax Income	$33M	$-85M	$-276M	$-228M
Income Tax	$31.0K	$-12.0K	$15.0K	$12.0K
Net Income	$33M	$-85M	$-276M	$-228M
EPS (Basic)	$2.61	$-11.41	$-65.19	$-2.24
EPS (Diluted)	$2.57	$-11.41	$-65.19	$-2.24
Shares (Basic)	12,544,000	7,488,000	4,236,000	101,990,000
Shares (Diluted)	12,718,000	7,488,000	4,236,000	101,990,000
EBITDA	$36M	$-83M	$-276M	$-281M

Neraca 23

Metrik	2025	2024	2023	2022
Cash & Equivalents	$8M	$25M	$26M	$93M
Short-term Investments	$0	$17M	$26M	$150M
Receivables	$1M	$1M	$34M	$40M
Inventory	$0	$11M	$10M	$2M
Other Current Assets	$2M	$10M	$6M	$10M
Current Assets	$12M	$65M	$102M	$295M
PP&E (Net)	$73.0K	$1M	$4M	$6M
PP&E (Gross)	$286.0K	$19M	$20M	$19M
Accum. Depreciation	$213.0K	$17M	$16M	$12M
Other Non-current Assets	$886.0K	$3M	$5M	$7M
Total Assets	$20M	$109M	$166M	$376M
Accounts Payable	$127.0K	$4M	$4M	$7M
Accrued Liabilities	$2M	$6M	$19M	$7M
Current Liabilities	$15M	$135M	$142M	$79M
Capital Leases	$9M	$30M	$46M	$58M
Other Non-current Liabilities	$2M	$3M	$5M	$6M
Total Liabilities	$59M	$206M	$265M	$250M
Common Stock	$1.0K	$1.0K	$0	$10.0K
Retained Earnings	$-2.02B	$-2.05B	$-1.97B	$-1.69B
AOCI	$1.0K	$8.0K	$-204.0K	$-2M
Stockholders' Equity	$-39M	$-97M	$99M	$127M
Liabilities + Equity	$20M	$109M	$166M	$376M
Shares Outstanding	7,324,000	5,859,000	4,258,000	95,927,000

Arus Kas 13

Metrik	2025	2024	2023	2022
D&A	$2M	$5M	$5M	$6M
Stock-based Comp	$10M	$27M	$45M	$54M
Deferred Tax	$0	$0	·	·
Restructuring	$13M	$5M	$7M	$6M
Operating Cash Flow	$-51M	$-69M	$-193M	$-270M
CapEx	$0	$246.0K	$1M	$4M
Investing Cash Flow	$18M	$9M	$124M	$203M
Stock Issued	$1M	$9M	$2M	$22M
Net Stock Activity	$1M	$9M	$2M	$22M
Financing Cash Flow	$16M	$59M	$2M	$53M
Taxes Paid	$190.0K	$24.0K	$2.0K	$19.0K
Free Cash Flow	$-51M	$-69M	$-194M	$-275M
Levered FCF	$-55M	$-74M	$-199M	·

Profitabilitas 7

Metrik	2025	2024	2023	2022
Operating Margin	29.7%	-64.7%	-3219.5%	·
Net Margin	27.1%	-66.2%	-3220.9%	·
Pretax Margin	27.1%	-66.2%	-3220.7%	·
EBITDA Margin	29.7%	-64.7%	-3219.5%	·
ROA	50.5%	-62.2%	-101.9%	-54.1%
ROE	-88.9%	90.9%	368.0%	-145.5%
ROIC	-93.0%	85.8%	278.2%	-221.5%

Likuiditas & Solvabilitas 3

Metrik	2025	2024	2023	2022
Current Ratio	0.8	0.5	0.7	3.7
Quick Ratio	0.7	0.3	0.6	3.6
Interest Coverage	9.5	-18.1	-52.2	·

Efisiensi 2

Metrik	Tren	2025	2024	2023	2022
Asset Turnover		1.9	0.9	0.0	·
Receivables Turnover		88.3	7.2	0.2	·

Per Saham 5

Metrik	2025	2024	2023	2022
Book Value / Share	$-5.26	$-16.60	$-0.93	$1.32
Revenue / Share	$9.50	$17.22	$0.08	·
Cash Flow / Share	$-4.01	$-9.18	$-1.82	$-2.65
Cash / Share	$1.16	$4.27	$0.24	$0.97
EPS (TTM)	$2.57	$-11.41	$-65.19	$-2.24

Tingkat Pertumbuhan 2

Metrik	Tren	2025	2024	2023	2022
Revenue YoY		-6.3%	1404.0%	-86.5%	·
Revenue CAGR 3Y		23.8%	·	·	·

Valuasi (TTM) 10

Metrik	2025	2024	2023	2022
Revenue TTM	$121M	$129M	$9M	$64M
Net Income TTM	$33M	$-85M	$-276M	$-228M
Market Cap	$132M	$78M	$1.37B	$7.87B
P/E	7.0	-1.2	-0.2	-36.6
P/S	1.1	0.6	159.2	123.7
P/B	-3.4	-0.8	-13.8	62.1
P / Tangible Book	·	·	13.8	62.1
P / Cash Flow	-2.6	-1.1	-7.1	-29.1
P / FCF	-2.6	-1.1	-7.0	-28.6
Earnings Yield	14.2%	-85.7%	-508.3%	-2.7%

Laporan Laba Rugi 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$630.0K	$516.0K	$2M	$3M	$18M	$98M	$33M	$40M	$29M	$27M	$4M	$2M	$957.0K	$1M	$221.0K	$4M
R&D Expense	$1M	$164.0K	$-223.0K	$3M	$7M	$27M	$29M	$44M	$33M	$46M	$50M	$57M	$56M	$62M	$63M	$70M
SG&A Expense	$4M	$4M	$4M	$4M	$7M	$11M	$9M	$10M	$9M	$11M	$11M	$12M	$13M	$14M	$13M	$19M
Operating Expenses	$5M	$4M	$4M	$7M	$14M	$59M	$45M	$62M	$47M	$59M	$64M	$72M	$72M	$76M	$76M	$89M
Operating Income	$-5M	$-3M	$-3M	$-4M	$3M	$39M	$-12M	$-22M	$-18M	$-31M	$-60M	$-70M	$-71M	$-75M	$-76M	$-85M
Interest Expense	$191.0K	$830.0K	$894.0K	$909.0K	$972.0K	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$117.0K	$123.0K
Interest Income	$78.0K	$54.0K	$100.0K	$204.0K	$143.0K	$236.0K	$597.0K	$459.0K	$450.0K	$604.0K	$711.0K	$1M	$2M	$2M	$1M	$973.0K
Other Non-op	$0	$0	$-49.0K	$4.0K	$22.0K	$-11.0K	$-89.0K	$555.0K	$-6.0K	$68.0K	$-12.0K	$-27.0K	$-10.0K	$-197.0K	$-68.0K	$-309.0K
Pretax Income	$-5M	$-4M	$-3M	$-4M	$2M	$38M	$-13M	$-22M	$-19M	$-32M	$-60M	$-70M	$-71M	$-75M	$-75M	$-84M
Income Tax	$1.0K	$0	$0	$28.0K	$3.0K	$0	$-19.0K	$-17.0K	$0	$24.0K	$11.0K	$-19.0K	$1.0K	$22.0K	$2.0K	$10.0K
Net Income	$-5M	$-4M	$-3M	$-4M	$2M	$38M	$-13M	$-22M	$-19M	$-32M	$-60M	$-70M	$-71M	$-75M	$-75M	$-84M
EPS (Basic)	$-0.32	$-0.29	$-0.80	$-0.32	$0.20	$3.53	$0.27	$-2.93	$-3.10	$-5.65	$-31.16	$-16.40	$-16.91	$-0.72	$-0.73	$-0.82
EPS (Diluted)	$-0.32	$-0.29	$-0.80	$-0.32	$0.19	$3.50	$0.27	$-2.93	$-3.10	$-5.65	$-31.16	$-16.40	$-16.91	$-0.72	$-0.73	$-0.82
Shares (Basic)	15,033,000	14,081,000	·	13,564,000	12,197,000	10,764,000	·	7,466,000	6,143,000	5,623,000	·	4,256,000	4,204,000	103,969,000	·	102,423,000
Shares (Diluted)	15,033,000	14,081,000	·	13,564,000	12,310,000	10,851,000	·	7,466,000	6,143,000	5,623,000	·	4,256,000	4,204,000	103,969,000	·	102,423,000
EBITDA	·	$-3M	·	$-4M	$3M	$39M	·	$-22M	$-18M	$-31M	·	$-70M	$-71M	$-75M	·	$-85M

Neraca 24

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$3M	$8M	$8M	$6M	$17M	$14M	$25M	$46M	$31M	$35M	$26M	$65M	$46M	$49M	$93M	$65M
Short-term Investments	$7M	·	$0	$8M	$5M	$0	$17M	$21M	$4M	$11M	$26M	$38M	$108M	$157M	$150M	$200M
Receivables	$318.0K	$0	$1M	$2M	$0	$9M	$1M	$1M	$2M	$36M	$34M	$163.0K	$507.0K	$397.0K	$40M	$249.0K
Inventory	·	·	$0	$0	$0	$0	$11M	$14M	$19M	$16M	$10M	$7M	$8M	$5M	$2M	·
Prepaid Expense	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$16M
Other Current Assets	$3M	$4M	$2M	$3M	$2M	$4M	$10M	$9M	$6M	$8M	$6M	$9M	$10M	$13M	$10M	·
Current Assets	$14M	$12M	$12M	$18M	$25M	$27M	$65M	$92M	$62M	$106M	$102M	$119M	$172M	$224M	$295M	$283M
PP&E (Net)	$41.0K	$55.0K	$73.0K	$147.0K	$176.0K	$285.0K	$1M	$2M	$2M	$3M	$4M	$5M	$5M	$6M	$6M	$7M
PP&E (Gross)	·	·	$286.0K	$551.0K	$551.0K	$2M	$19M	$20M	$20M	$20M	$20M	$20M	$20M	$19M	$19M	$20M
Accum. Depreciation	·	·	$213.0K	$404.0K	$375.0K	$2M	$17M	$18M	$17M	$17M	$16M	$15M	$14M	$13M	$12M	$12M
Other Non-current Assets	$765.0K	$890.0K	$886.0K	$881.0K	$927.0K	$3M	$3M	$3M	$4M	$4M	$5M	$6M	$7M	$7M	$7M	$7M
Total Assets	$21M	$20M	$20M	$30M	$37M	$62M	$109M	$143M	$117M	$165M	$166M	$189M	$246M	$302M	$376M	$368M
Accounts Payable	$824.0K	$637.0K	$127.0K	$318.0K	$2M	$1M	$4M	$2M	$5M	$3M	$4M	$7M	$4M	$5M	$7M	$11M
Accrued Liabilities	$2M	$2M	$2M	$3M	$5M	$9M	$6M	$8M	$11M	$18M	$19M	$8M	$11M	$7M	$7M	·
Current Liabilities	$7M	$6M	$15M	$18M	$15M	$48M	$135M	$156M	$148M	$181M	$142M	$79M	$75M	$68M	$79M	$72M
Capital Leases	$9M	$9M	$9M	$15M	$15M	$27M	$30M	$35M	$39M	$42M	$46M	$49M	$52M	$55M	$58M	$61M
Other Non-current Liabilities	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$6M	$6M
Total Liabilities	$58M	$57M	$59M	$67M	$72M	$117M	$206M	$233M	$228M	$264M	$265M	$240M	$239M	$237M	$250M	$181M
Common Stock	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$0	$12.0K	$0	$10.0K	$10.0K	$10.0K	$10.0K	$9.0K
Retained Earnings	$-2.03B	$-2.03B	$-2.02B	$-2.02B	$-2.01B	$-2.02B	$-2.05B	$-2.04B	$-2.02B	$-2.00B	$-1.97B	$-1.91B	$-1.84B	$-1.77B	$-1.69B	$-1.62B
AOCI	$-2.0K	$0	$1.0K	$2.0K	$0	$0	$8.0K	$22.0K	$-14.0K	$-55.0K	$-204.0K	$-571.0K	$-933.0K	$-1M	$-2M	$-3M
Stockholders' Equity	$-37M	$-37M	$-39M	$-37M	$-35M	$-55M	$-97M	$-91M	$-111M	$-98M	$-99M	$-51M	$7M	$65M	$127M	$187M
Liabilities + Equity	$21M	$20M	$20M	$30M	$37M	$62M	$109M	$143M	$117M	$165M	$166M	$189M	$246M	$302M	$376M	$368M
Shares Outstanding	9,443,000	8,512,000	7,324,000	7,210,000	6,978,000	5,924,000	5,859,000	5,740,000	4,904,000	120,325,000	4,258,000	101,922,000	101,102,000	96,538,000	95,927,000	94,879,000

Arus Kas 12

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$14.0K	$29.0K	$49.0K	$36.0K	$236.0K	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M
Stock-based Comp	$394.0K	$749.0K	$2M	$1M	$3M	$4M	$6M	$6M	$6M	$8M	$10M	$11M	$13M	$12M	$11M	$14M
Restructuring	$767.0K	$0	$1M	$27.0K	$2M	$10M	$0	$0	$356.0K	$5M	$7M	$0	$0	$45.0K	$74.0K	$6M
Operating Cash Flow	$-3M	$-3M	$-6M	$-10M	$-7M	$-28M	$-24M	$-4M	$-11M	$-30M	$-50M	$-51M	$-53M	$-38M	$-57M	$-65M
CapEx	·	·	$0	$0	$0	$0	$90.0K	$0	$29.0K	$127.0K	$44.0K	$281.0K	$499.0K	$399.0K	$37.0K	$132.0K
Investing Cash Flow	$-7M	$0	$8M	$-2M	$-5M	$17M	$3M	$-17M	$7M	$15M	$10M	$70M	$49M	$-6M	$51M	$60M
Stock Issued	$5M	$3M	$-25.0K	$1M	$0	$0	$0	$0	$-26.0K	$9M	$2M	$0	$-50.0K	$640.0K	$1M	$0
Net Stock Activity	·	$3M	·	·	·	$0	·	·	·	$9M	·	·	·	$640.0K	·	·
Financing Cash Flow	$5M	$3M	$-3.0K	$1M	$15M	$-250.0K	$-328.0K	$36M	$-324.0K	$24M	$2M	$-208.0K	$471.0K	$235.0K	$32M	$-214.0K
Taxes Paid	·	·	$159.0K	$28.0K	$3.0K	$0	$0	$0	$0	$24.0K	$0	$0	$1.0K	$1.0K	$0	$0
Free Cash Flow	·	·	·	·	·	$-28M	·	·	·	$-30M	·	·	·	$-39M	·	·
Levered FCF	·	·	·	·	·	$-29M	·	·	·	$-31M	·	·	·	$-40M	·	·

Profitabilitas 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	·	-652.9%	·	-103.5%	18.2%	39.5%	·	-54.1%	-63.7%	-114.2%	·	-3255.9%	-7462.3%	-6118.9%	·	·
Net Margin	·	-803.3%	·	-124.6%	13.6%	38.7%	·	-54.5%	-66.5%	-116.1%	·	-3264.6%	-7430.3%	-6098.8%	·	·
Pretax Margin	·	-803.3%	·	-123.8%	13.6%	38.7%	·	-54.6%	-66.5%	-116.0%	·	-3265.5%	-7430.2%	-6097.0%	·	·
EBITDA Margin	·	-652.9%	·	-103.5%	18.2%	39.5%	·	-54.1%	-63.7%	-114.2%	·	-3255.9%	-7462.3%	-6118.9%	·	·
ROA	·	-10.1%	·	-5.0%	3.1%	33.4%	·	-13.2%	-10.5%	-13.6%	·	-25.1%	-20.8%	-21.4%	·	-20.5%
ROE	·	9.0%	·	6.8%	-3.3%	-49.6%	·	31.0%	36.8%	190.4%	·	-102.4%	-53.7%	-51.7%	·	-33.8%
ROIC	·	9.0%	·	9.8%	-9.1%	-70.5%	·	24.0%	16.4%	31.8%	·	136.9%	-958.1%	-115.5%	·	-45.2%

Likuiditas & Solvabilitas 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	·	2.2	·	1.0	1.7	0.6	·	0.6	0.4	0.6	·	1.5	2.3	3.3	·	3.9
Quick Ratio	·	1.5	·	0.9	1.5	0.5	·	0.4	0.3	0.5	·	1.3	2.1	3.0	·	3.7
Interest Coverage	·	-4.1	·	-3.9	3.3	38.2	·	-18.4	-14.4	-27.1	·	-49.9	-51.8	-56.2	·	·

Efisiensi 2

Metrik	Tren	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		·	0.0	·	0.0	0.2	0.9	·	0.2	0.2	0.1	·	0.0	0.0	0.0	·	·
Receivables Turnover		·	0.1	·	2.1	14.5	4.4	·	53.7	19.6	1.5	·	10.4	1.7	2.3	·	·

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$-4.38	·	$-5.08	$-5.02	$-9.30	·	$-15.77	$-22.61	$-0.82	·	$-0.50	$0.07	$0.67	·	$1.97
Revenue / Share	·	$0.04	·	$0.25	$1.43	$9.05	·	$5.38	$4.66	$0.19	·	$0.02	$0.01	$0.01	·	·
Cash Flow / Share	·	$-0.22	·	·	·	$-2.59	·	·	·	$-0.21	·	·	·	$-0.37	·	·
Cash / Share	·	$0.98	·	$0.80	$2.42	$2.34	·	$8.09	$6.39	$0.29	·	$0.64	$0.45	$0.50	·	$0.69
EPS (TTM)	$-0.74	$-1.22	·	$3.64	$1.03	$-2.26	·	$-42.84	$-56.31	$-70.12	·	$-34.76	$-19.18	$-2.09	·	$-2.47

Valuasi (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$22M	$23M	·	$152M	$189M	$200M	·	$100M	$62M	$35M	·	$5M	$7M	$57M	·	·
Net Income TTM	$-11M	$-9M	·	$23M	$6M	$-16M	·	$-133M	$-181M	$-233M	·	$-290M	$-305M	$-215M	·	$-247M
Market Cap	·	$40M	·	$103M	$54M	$35M	·	$47M	$42M	$2.09B	·	$3.77B	$4.07B	$7.00B	·	$8.97B
P/E	-15.5	-3.9	·	3.9	7.5	-2.6	·	-0.2	-0.2	-0.2	·	-1.1	-2.1	-34.7	·	-38.3
P/S	·	1.7	·	0.7	0.3	0.2	·	0.5	0.7	60.2	·	830.3	592.9	121.8	·	·
P/B	·	-1.1	·	-2.8	-1.5	-0.6	·	-0.5	-0.4	-21.2	·	-74.2	545.9	107.7	·	47.9
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	·	545.9	107.7	·	47.9
P / Cash Flow	·	-13.1	·	·	·	-1.3	·	·	·	-70.5	·	·	·	-182.1	·	·
Earnings Yield	-6.5%	-25.8%	·	25.4%	13.3%	-38.0%	·	-526.9%	-662.5%	-404.2%	·	-94.0%	-47.6%	-2.9%	·	-2.6%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$121M	$129M	$9M	$64M	·
Margin Operasi %	29.7%	-64.7%	-3219.5%	·	·
Laba Bersih	$33M	$-85M	$-276M	$-228M	$-340M
EPS Dilusian	$2.57	$-11.41	$-65.19	$-2.24	$-3.63

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rasio Lancar	0.8	0.5	0.7	3.7	3.6
Rasio Cepat	0.7	0.3	0.6	3.6	3.5

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$-51M	$-69M	$-194M	$-275M	$-231M

Pemilik institusional (13F) 38 pengaju · $54.9M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 38

Nilai yang dipegang $54.9M

Posisi baru 4

Posisi yang keluar 1

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
4 (-3 vs Kuartal sebelumnya)	1 (-13 vs Kuartal sebelumnya)	12 (+2 vs Kuartal sebelumnya)	8 (+5 vs Kuartal sebelumnya)	+1.9M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
EcoR1 Capital, LLC	$17.816.960	1.552.000	32,43%	Saham
ADAGE CAPITAL PARTNERS GP, L.L.C.	$9.758.000	850.000	17,76%	Saham
Point72 Asset Management, L.P.	$7.895.003	687.718	14,37%	Saham
Redmile Group, LLC	$5.070.727	441.701	9,23%	Saham
VANGUARD GROUP INC	$4.087.255	225.940	7,44%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$2.836.100	247.047	5,16%	Saham
MACKENZIE FINANCIAL CORP	$2.677.699	233.249	4,87%	Saham
BlackRock, Inc.	$969.544	84.455	1,76%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$862.924	75.128	1,57%	Saham
STALEY CAPITAL ADVISERS INC	$574.000	50.000	1,04%	Saham
VANGUARD FIDUCIARY TRUST CO	$494.053	43.036	0,90%	Saham
JANE STREET GROUP, LLC	$348.360	30.345	0,63%	Saham
STATE STREET CORP	$303.680	26.453	0,55%	Saham
NORTHERN TRUST CORP	$190.465	16.591	0,35%	Saham
FMR LLC	$186.412	16.238	0,34%	Saham
XTX Topco Ltd	$175.678	15.303	0,32%	Saham
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$160.720	14.000	0,29%	Saham
MILLENNIUM MANAGEMENT LLC	$145.566	12.680	0,26%	Saham
CITADEL ADVISORS LLC	$116.625	10.159	0,21%	Saham
MORGAN STANLEY	$105.368	9.178	0,19%	Saham
ROYAL BANK OF CANADA	$55.000	4.743	0,10%	Saham
UBS Group AG	$45.679	3.979	0,08%	Saham
Vanguard Global Advisers, LLC	$16.715	1.456	0,03%	Saham
SBI Securities Co., Ltd.	$16.118	1.404	0,03%	Saham
JONES FINANCIAL COMPANIES LLLP	$8.440	803	0,02%	Saham
Caitong International Asset Management Co., Ltd	$3.570	311	0,01%	Saham
BARCLAYS PLC	$3.490	304	0,01%	Saham
Banque Transatlantique SA	$3.096	176	0,01%	Saham
WELLS FARGO & COMPANY/MN	$2.881	251	0,01%	Saham
JPMORGAN CHASE & CO	$2.413	216	0,00%	Saham
Raiffeisen Bank International AG	$2.296	200	0,00%	Opsi beli
CITIGROUP INC	$1.114	97	0,00%	Saham
BNP PARIBAS FINANCIAL MARKETS	$528	46	0,00%	Saham
ACADIAN ASSET MANAGEMENT LLC	$444	38.845	0,00%	Saham
PlanVest Financial, Inc	$321	28	0,00%	Saham
KERR FINANCIAL PLANNING Corp	$276	24	0,00%	Saham
OSAIC HOLDINGS, INC.	$114	10	0,00%	Saham
Rockefeller Capital Management L.P.	$92	8	0,00%	Saham

Aktivis & pemilik 5%+ 3 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
Redmile Group, LLC, Green Jeremy, Redmile Biopharma Investments II, L.P., Redmile Strategic Long Only Trading Sub, Ltd. ×4 pengajuan	24 Juli 2026	9,90%	Amandemen	·	SEC
Panacea Innovation Limited, Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., Panacea Opportunity Fund I, L.P., Panacea Opportunity Fund I GP Company, Ltd., James Huang ×4 pengajuan	11 Mei 2026	16,10%	Amandemen	·	SEC
Adiumentum Capital Fund I LP, Adiumentum Capital Fund I GP LLC, Gregory A. Ciongoli ×3 pengajuan	16 Mei 2025	19,99%	Amandemen	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 35 orang dalam · 19 pejabat · 16 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Beli 12m	Jual 12m	Bersih 12m
Anhco Nguyen	President and CEO	17 Agu 2026 S	132.775	0	8	$-142.448
Isaac E. Ciechanover	Chief Executive Officer	30 Mei 2019 S	290.687	0	0	$0
Utpal Koppikar	Chief Financial Officer	2 Maret 2023 S	181.978	0	0	$0
John Mcgrath	EVP & Chief Financial Officer	20 Maret 2018 S	88.762	0	0	$0
Yanina Grant-Huerta	Chief Accounting Officer	18 Mei 2026 S	49.636	0	8	$-56.523
Jill Henrich	EVP, Chief Regulatory Officer	3 Maret 2025 S	18.679	0	0	$0
Amar Murugan	EVP, Chief Legal Officer	16 Agu 2024 S	26.827	0	0	$0
Manher Joshi	EVP, Chief Medical Officer	16 Nov. 2023 S	171.284	0	0	$0
Charlene A. Banard	EVP, Chief Technical Officer	16 Mei 2023 S	276.010	0	0	$0
Jakob Dupont	EVP, Head of R&D	2 Maret 2023 S	290.794	0	0	$0
Kristin Yarema	Chief Commercial Officer	1 Maret 2022 A	171.415	0	0	$0
Joe Newell	Chief Operations Officer	16 Nov. 2021 S	113.097	0	0	$0
Dietmar Berger	Global Head of R&D	7 Mei 2019 F	85.678	0	0	$0
Mina Kim	Senior VP & General Counsel	9 April 2019 F	66.389	0	0	$0
Derrell Porter	SVP, Head of Global Commercial	26 Maret 2019 A	31.688	0	0	$0
Christopher Haqq	EVP, R&D & Chief Scientific Of	15 Feb. 2019 S	271.943	0	0	$0
Gad Soffer	EVP & Chief Strategy Officer	22 Sep. 2018 F	243.966	0	0	$0
Mitchall G. Clark	EVP & Chief R & QA Officer	18 Mei 2018 S	107.972	0	0	$0
Heather D Turner	Former EVP, GC & Sec.	9 Feb. 2018 S	69.494	0	0	$0
Brian N Cherry	Direktur	4 Sep. 2026 P	166.486	1	0	$999.994
Gregory A. Ciongoli	Direktur	9 Juni 2026 A	12.000	0	0	$0
Matthew K Fust	Direktur	9 Juni 2026 A	30.188	0	0	$0
William K Heiden	Direktur	9 Juni 2026 A	34.188	0	0	$0
Ameet Mallik	Direktur	10 Juni 2025 A	16.928	0	0	$0
Maria Grazia Roncarolo	Direktur	10 Juni 2025 A	17.368	0	0	$0
Pascal Touchon	Direktur	10 Juni 2025 A	77.955	0	0	$0
Carol Giltner Gallagher	Direktur	10 Juni 2025 A	33.012	0	0	$0
Eric Dobmeier	Direktur	10 Nov. 2023 P	563.325	0	0	$0
Beth C Seidenberg	Direktur	31 Mei 2023 A	115.689	0	0	$0
Roy D. Baynes	Direktur	23 Juni 2022 A	43.500	0	0	$0
Ronald C Renaud JR	Direktur	23 Juni 2022 A	31.500	0	0	$0
Joel S Marcus	Direktur	15 Maret 2019 S	888.355	0	0	$0
Eckard Weber	Direktur	16 Jan. 2015 A	·	0	0	$0
EcoR1 Capital, LLC	Pemilik 10%	7 Mei 2026 P	1.552.000	1	0	$4.744.255
Eric J Hyllengren	·	31 Maret 2025 D	56.231	0	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 4 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
IWC · iShares Trust	0,01%	18.824 SH	11 Sep. 2026	Harian
VXF · VANGUARD INDEX FUNDS	0,00%	82.758 SH	19 Agu 2026	Harian
VTI · VANGUARD INDEX FUNDS	0,00%	158.646 SH	19 Agu 2026	Harian
DFAS · Dimensional ETF Trust	0,00%	135 NS	31 Juli 2026	N-PORT

ATRA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 10 analis BELI

Target median $13.00 +37,1%

2 20,0% Beli Kuat

6 60,0% Beli

2 20,0% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

3 analis · 2026-10-02

Target rata-rata $13.67 +44,2%

← Di bawah semua target Harga saat ini $9.48

Rendah$10.00 Rata-rata$13.67 Tinggi$18.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
ATRA	$132M	7.0	-6.3%	27.1%	-88.9%	·
CNXU	·	·	·	·	·	·
RLYB	$4M	-0.4	34.9%	-1046.4%	-17.3%	·
MNOV	$64M	-5.5	·	-2928.8%	-27.1%	·
ICCC	·	-51.2	4.3%	·	·	·
ACRV	$76M	-1.2	·	·	-61.0%	·
SERA	·	-4.4	5.2%	-39417.3%	-39.0%	·
GRML	·	·	·	·	-104.9%	·
GANX	$135M	-5.3	-60.6%	·	-181.1%	·

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

ATRA Atara Biotherapeutics, Inc. - Common Stock